The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
OlympiA: A phase III, multicenter, randomized, placebo-controlled trial of adjuvant olaparib after (neo)adjuvant chemotherapy in patients with germline BRCA1/2 mutations and high-risk HER2-negative early breast cancer.
Andrew Tutt
Employment - Institute of Cancer Research
Leadership - Institute of Cancer Research
Stock and Other Ownership Interests - InBiomotion
Honoraria - Medscape; Prime Oncology
Consulting or Advisory Role - Artios; AstraZeneca; Merck Serono (Inst); Pfizer; Prime Oncology
Research Funding - Artios (Inst); AstraZeneca (Inst); Merck KGaA (Inst); Roche/Genentech (Inst)
Patents, Royalties, Other Intellectual Property - I have i the past and may in the future be in Receipt of payments under my employer (ICR London) Rewards to inventors Scheme associated with patents held by ICR associated with the use of PARP inhibitors in BRCA 1/2 deficient cancers
Travel, Accommodations, Expenses - AstraZeneca; Pfizer
Other Relationship - Breast Cancer Now Charity (Inst); Cancer Research UK (Inst)
(OPTIONAL) Uncompensated Relationships - St Gallen Early Breast Cancer Consensus Conference
Judy Ellen Garber
Consulting or Advisory Role - Aleta BioTherapeutics (I); GTx (I); H3 Biomedicine (I); Helix BioPharma; Konica Minolta; Kronos Bio (I); Novartis (I)
Research Funding - Ambry Genetics; InVitae; Myriad Genetics; Novartis (I)
Other Relationship - AACR; Adrienne Helis Malvin Medical Research Foundation (I); Breast Cancer Research Foundation; Diana Helis Henry Medical Foundation (I); Facing our Risk of Cancer Empowered; James P. Wilmot Foundation (I); Susan G. Komen for the Cure (I)
Bella Kaufman
Honoraria - AstraZeneca; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Novartis; Pfizer; Roche
Speakers' Bureau - Novartis; Roche
Travel, Accommodations, Expenses - Roche
Giuseppe Viale
Honoraria - Daiichi Sankyo Europe GmbH; MSD Oncology; Pfizer
Consulting or Advisory Role - Bayer; Daiichi Sankyo; Dako; Menarini; MSD Oncology; Novartis; Roche/Genentech
Speakers' Bureau - Roche/Genentech
Research Funding - Cepheid (Inst); Dako/Agilent Technologies (Inst); Roche/Genentech; Ventana Medical Systems (Inst)
Travel, Accommodations, Expenses - Roche
Debora Fumagalli
Research Funding - AstraZeneca (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); SERVIER (Inst); Tesaro (Inst)
Priya Rastogi
Travel, Accommodations, Expenses - AstraZeneca; Genentech/Roche; Lilly
Richard D. Gelber
Research Funding - AstraZeneca (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Novartis; Roche
Evandro de Azambuja
Honoraria - Roche/Genentech; Seattle Genetics; Zodiac Pharma
Consulting or Advisory Role - Libbs; Novartis; Pierre Fabre; Roche/Genentech
Research Funding - AstraZeneca (Inst); GlaxoSmithKline/Novartis (Inst); Roche/Genentech (Inst); Servier/Pfizer (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline; Roche/Genentech
Anitra Fielding
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
Judith Balmana Gelpi
Consulting or Advisory Role - AstraZeneca; Pfizer
Research Funding - AstraZeneca (Inst)
Patents, Royalties, Other Intellectual Property - European patent request submitted (EP17382884.9) not related to this work
Travel, Accommodations, Expenses - AstraZeneca; Pfizer
Karen A. Gelmon
Honoraria - AstraZeneca; Merck Sharp & Dohme; Novartis Canada Pharmaceuticals Inc; Seattle Genetics
Consulting or Advisory Role - AstraZeneca; Ayala Pharmaceuticals; Bristol-Myers Squibb; Genomic Health; Janssen Oncology; Lilly; Merck; Mylan; NanoString Technologies; Novartis; Pfizer; Roche
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Pfizer (Inst); Roche (Inst)
Expert Testimony - Genentech
Nigel Baker
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
Amal Arahmani
Research Funding - AstraZeneca (Inst); BIOVICA (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); SANOFI (Inst); SERVIER (Inst); TESARO (Inst)
Elzbieta Senkus-Konefka
Stock and Other Ownership Interests - AstraZeneca; Lilly; Pfizer
Honoraria - Amgen; AstraZeneca; Egis Pharmaceuticals; Genomic Health; Lilly; Novartis; Oncompass; Pfizer; Pierre Fabre; Roche; Sandoz; TLC Biopharmaceuticals
Research Funding - Amgen; AstraZeneca; Lilly; Novartis; Pfizer; Roche; Samsung
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Egis Pharmaceuticals; Novartis; Pfizer; Roche
Eleanor Mc Fadden
Research Funding - AstraZeneca (Inst); Novartis (Inst); Roche (Inst)
Vassiliki Karantza
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck Sharp & Dohme
Sunil R. Lakhani
Honoraria - Roche (Inst)
Consulting or Advisory Role - Suburban Hosptial (Inst)
Speakers' Bureau - Roche (Inst)
Travel, Accommodations, Expenses - Ventana Medical Systems
Greg Yothers
Employment - Mountainview Pediatrics (I)
Consulting or Advisory Role - Orbus Therapeutics
Christine Campbell
No Relationships to Disclose
Charles E. Geyer
Honoraria - Athenex; Exact Sciences
Research Funding - Genentech/Roche
Travel, Accommodations, Expenses - Abbvie; Daiichi-Sankyo; Genentech/Roche